Navigation Links
PharmaVentures Appoints Paul Phull as Senior Director

PharmaVentures Appoints Paul Phull as Senior Director -- OXFORD, England, August 31, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements Click to view news release full screen  

PharmaVentures Appoints Paul Phull as Senior Director


OXFORD, England, August 31, 2010 /PRNewswire/ --

- New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

PharmaVentures Ltd ( ("PharmaVentures") today announced that Paul Phull has joined the company as Senior Director. With more than 24 years of senior level commercial, business/corporate development and general management experience in the pharmaceutical, biotechnology and medical device industries, Paul will be responsible for developing PharmaVentures' Corporate Advisory business.

Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialty pharmaceutical company, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries. He was also responsible for corporate development and worked on the acquisition and integration of European sales and marketing companies in France, Spain and Italy into the Sinclair group. Paul has significant deal making and corporate transaction experience with a broad range and size of companies in Europe, USA, Japan, India and Asia in a number of therapeutic areas.

"I am very pleased to welcome Paul to PharmaVentures," said Dr Fintan Walton, Chief Executive Officer. "His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings."

About PharmaVentures

PharmaVentures Limited ( is based in Oxford, England and is a leading international corporate advisory firm supporting its clients' growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and government bodies. It also produces the highly popular PharmaDeals(R) range of intelligence products including analysis tools and reports. In 2006 it launched the world's first dedicated online pharmaceutical television channel PharmaTelevision(R) (

Doug Cookson Commercial Director, PharmaVentures T: +44(0)1865-332731 E:

SOURCE PharmaVentures
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
2. Jennerex Appoints Lara Longpre to Chief Operating Officer
3. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
4. Fluidnet Corporation Appoints Benjamin E. Bulkley President and Chief Executive Officer
5. Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
6. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
7. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
8. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
9. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
10. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
11. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... the "Medium Molecular Weight Polyisobutylene Market ... Other Applications - Global Industry Analysis, Size, ... 2023" report to their offering. ... addition of the "Medium Molecular Weight ...
(Date:12/1/2015)... 1, 2015   Nottingham Spirk , a ... the publication of a free whitepaper , ... Market". The whitepaper gives medical product companies, pharmaceutical ... this lucrative segment. Nottingham Spirk ... manage their own health, save money (i.e., fewer ...
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... World Patent Marketing , ... a container patent that allows for easier packing and organizing of items into one ... $90 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing and ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services ... Jordan Industries International, LLC (“JII”). , With support from JII, Integrated Rental is ... to hospitals, surgery centers, clinics, research labs and medical facilities across the United ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... ... It’s official: Tattoo taboo is a thing of the past. One in five ... one in three aged 18 to 25 is inked). As tattoos transition to mainstream ... fact, RealSelf , the world’s largest community for learning and sharing information about ...
Breaking Medicine News(10 mins):